Greenwood Capital Associates LLC Gilead Sciences, Inc. Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$71.58 - $87.29 $207,939 - $253,577	2,905 Added 8.29%	37,958 $2.78 Million
Q4 2023 Mar 05, 2024	SELL	$73.27 - $83.09 $4,029 - $4,569	-55 Reduced 0.16%	35,053 $2.84 Million
Q3 2023 Oct 18, 2023	SELL	$73.94 - $80.67 $147 - $161	-2 Reduced 0.01%	35,108 $2.63 Million
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $108,694 - $123,981	1,430 Added 4.25%	35,110 $2.71 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $314,574 - $358,397	4,069 Added 13.74%	33,680 $2.79 Million
Q4 2022 Jan 26, 2023	SELL	$62.32 - $89.47 $515,760 - $740,453	-8,276 Reduced 21.84%	29,611 $0
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $88,476 - $101,062	1,486 Added 4.08%	37,887 $2.34 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $101,471 - $114,287	1,758 Added 5.07%	36,401 $2.25 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $1.01 Million - $1.27 Million	17,476 Added 101.8%	34,643 $2.06 Million
Q4 2021 Feb 03, 2022	BUY	$64.88 - $73.64 $311,359 - $353,398	4,799 Added 38.8%	17,167 $1.25 Million
Q3 2021 Oct 27, 2021	BUY	$67.69 - $73.03 $353,951 - $381,873	5,229 Added 73.25%	12,368 $864,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $453,112 - $495,089	7,139 New	7,139 $492,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $2.82 Million - $3.55 Million	-45,486 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $1.18 Million - $1.37 Million	-16,348 Reduced 26.44%	45,486 $3.5 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $2.04 Million - $2.61 Million	-32,531 Reduced 34.47%	61,834 $4.62 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $1.68 Million - $1.85 Million	27,345 Added 40.8%	94,365 $6.13 Million
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $68,135 - $75,210	-1,090 Reduced 1.73%	61,775 $4.17 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $327,864 - $361,905	5,245 Added 8.49%	67,020 $4.25 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $3.89 Million - $4.36 Million	62,865 New	62,865 $4.25 Million
Q2 2018 Aug 07, 2018	SELL	$64.88 - $75.68 $3.56 Million - $4.16 Million	-54,911 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $1.2 Million - $1.46 Million	-16,439 Reduced 23.04%	54,911 $4.14 Million
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $630,317 - $739,903	-8,859 Reduced 11.04%	71,350 $5.11 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $5.78 Million - $6.86 Million	80,209	80,209 $6.5 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account